US 8367052
Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies
granted A61KA61K2039/505A61K31/282
Quick answer
US patent 8367052 (Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies) held by GENERAL REGENERATIVES, LTD. expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GENERAL REGENERATIVES, LTD.
- Grant date
- Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K31/282, A61K31/351, A61K31/498